STOCK TITAN

Vir Biotechnology to Participate in the Cowen 43rd Annual Health Care Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Vir Biotechnology has announced that Bolyn Hubby, Ph.D., the Executive Vice President and Chief Corporate Affairs Officer, will participate in a panel about infectious diseases at the Cowen 43rd Annual Health Care Conference. This event is scheduled for March 7, 2023, at 6:10 a.m. PT / 9:10 a.m. ET. A live webcast of the panel will be available on the Vir website under the Events & Presentations section and will remain accessible for 30 days.

Vir Biotechnology focuses on innovative solutions to treat serious infectious diseases through advanced immunological technologies. Its development pipeline includes candidates for COVID-19, hepatitis B and D, influenza A, and HIV.

Positive
  • None.
Negative
  • None.

SAN FRANCISCO, Feb. 28, 2023 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that Bolyn Hubby, Ph.D., Executive Vice President and Chief Corporate Affairs Officer, will participate in a panel focused on infectious diseases at the Cowen 43rd Annual Health Care Conference on Tuesday, March 7, at 6:10 a.m. PT / 9:10 a.m. ET.

A live webcast of the panel can be accessed under Events & Presentations in the Investors section of the Vir website at www.vir.bio and will be archived there for 30 days.

About Vir Biotechnology
Vir Biotechnology is a commercial-stage immunology company focused on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases. Vir has assembled four technology platforms that are designed to stimulate and enhance the immune system by exploiting critical observations of natural immune processes. Its current development pipeline consists of product candidates targeting COVID-19, hepatitis B and D viruses, influenza A and human immunodeficiency virus. Vir routinely posts information that may be important to investors on its website.


FAQ

What is the date and time of the Vir Biotechnology panel at the Cowen Conference?

The panel will take place on March 7, 2023, at 6:10 a.m. PT / 9:10 a.m. ET.

Who from Vir Biotechnology will participate in the infectious diseases panel?

Bolyn Hubby, Ph.D., Executive Vice President and Chief Corporate Affairs Officer, will participate.

Where can I watch the Vir Biotechnology panel discussion?

The panel discussion can be accessed via a live webcast on the Vir website, under the Events & Presentations section.

How long will the Vir Biotechnology panel webcast be available?

The webcast will be archived on the Vir website for 30 days.

What infectious diseases does Vir Biotechnology target in its pipeline?

Vir Biotechnology's pipeline includes product candidates targeting COVID-19, hepatitis B and D, influenza A, and HIV.

Vir Biotechnology, Inc.

NASDAQ:VIR

VIR Rankings

VIR Latest News

VIR Stock Data

1.72B
117.08M
11.9%
74.31%
4.42%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States of America
SAN FRANCISCO